SCHEMBL8551091

SCHEMBL8551091

c1ccc2c(CCN3CCC(c4cc(-c5ccc6c(c5)OCCO6)[nH]n4)CC3)c[nH]c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.53
DRD2 P14416 6/20 0.52
HTR2A P28223 1/20 0.46
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
ADRA1D P25100 1/20 0.42
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HTR6 P50406 1/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8551088 0.86 HTR2A (0.42) HTR1ADRD2HTR2AADRA2AADRA2B
SCHEMBL8545434 0.86 DRD2 (0.40) HTR1ADRD2ADRA1DADRA1AADRA1B
SCHEMBL8917850 0.84 HTR1A (0.40) HTR1ADRD2HTR2AMEN1NPC1
SCHEMBL8546423 0.81 SNCA (0.42) HTR1ADRD2ADRA1DADRA1AADRA1B
SCHEMBL8545455 0.81 DRD2 (0.50) HTR1ADRD2HTR2AADRA2AADRA2B
SCHEMBL1388497 0.75 DRD2 (0.56) HTR1ADRD2HTR2AADRA2AADRA2B
SCHEMBL8549889 0.72 SLC6A4 (0.44) HTR1ADRD2ADRA1DADRA1AADRA1B
SCHEMBL8545428 0.72 ADRA1D (0.39) HTR1ADRD2ADRA1DADRA1AADRA1B
SCHEMBL8917837 0.71 HTR1A (0.37) HTR1ADRD2HTR2A
SCHEMBL6465788 0.71 HTR2A (0.88) HTR1ADRD2HTR2AADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0822814-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-12-09 EP claimed
EP-0822814-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-02-11 EP claimed
WO-1996032938-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-10-24 WO claimed
EP-0822814-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-12-09 EP disclosed
EP-0822814-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-02-11 EP disclosed
US-5668148-A BENIGN PROSTATIC HYPERTROPHY MERCK & CO., INC. (US) 1997-09-16 US disclosed
WO-1996032938-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-10-24 WO disclosed